Tjandrawinata, R.R.; Harbuwono, D.S.; Soegondo, S.; Taslim, N.A.; Nurkolis, F.
Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management. Pharmaceuticals 2025, 18, 1101.
https://doi.org/10.3390/ph18081101
AMA Style
Tjandrawinata RR, Harbuwono DS, Soegondo S, Taslim NA, Nurkolis F.
Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management. Pharmaceuticals. 2025; 18(8):1101.
https://doi.org/10.3390/ph18081101
Chicago/Turabian Style
Tjandrawinata, Raymond Rubianto, Dante Saksono Harbuwono, Sidartawan Soegondo, Nurpudji Astuti Taslim, and Fahrul Nurkolis.
2025. "Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management" Pharmaceuticals 18, no. 8: 1101.
https://doi.org/10.3390/ph18081101
APA Style
Tjandrawinata, R. R., Harbuwono, D. S., Soegondo, S., Taslim, N. A., & Nurkolis, F.
(2025). Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management. Pharmaceuticals, 18(8), 1101.
https://doi.org/10.3390/ph18081101